TOP TIERMARKET NEWSWIRE
SEC Form 4 history

DIANTHUS THERAPEUTIC (DNTH) insider trades

DIANTHUS THERAPEUTIC (DNTH) insider trading activity (SEC Form 4). Over the trailing 90 days, DNTH insiders filed 0 purchases totalling $0 and 8 sales totalling $29.3M — net SELLING of $29.3M. Most recent filing: Sep 18, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
8
$29.3M
Net (90d)
-$29.3M
net selling
Most recent
Sep 18, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 18, 2026Carr EdwardCHIEF ACCOUNTING OFFICERS SaleOE—$101.38$2.0Mfiling
Sep 3, 2026Randhawa SimratEVP, Head of R, DS SaleOE—$106.41$2.5Mfiling
Aug 19, 2026Read SimonDirS SaleOE—$117.55$327Kfiling
Aug 11, 2026McGeorge AnneDirS SaleOE—$109.01$845Kfiling
Aug 11, 2026Read SimonDirS SaleOE—$109.55$304Kfiling
Aug 11, 2026Veness Adam MSVP, GC, Sec.S SaleOE—$110.44$2.2Mfiling
Aug 7, 2026Garcia MarinoCEO, PresS SaleOE—$108.11$17.9Mfiling
Jul 13, 2026Savitz RyanEVP, CFO, CBOS SaleOE—$101.03$3.2Mfiling
Jun 18, 2026Veness Adam MSVP, GC, Sec.S SaleOE—$80.80$2.4Mfiling
Jun 2, 2026Randhawa SimratEVP, Head of R, DS SaleOE—$90.62$2.4Mfiling
May 11, 2026Soteropoulos PaulaDirS SaleOE—$85.47$51Kfiling